# SRS (Stereotactic Radiosurgery) Plus Ipilimumab

> **NCT01950195** · PHASE1 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 4 (actual)

## Conditions studied

- Newly Diagnosed Melanoma Metastases in the Brain and Spine

## Interventions

- **PROCEDURE:** Stereotactic Radiosurgery (SRS)
- **BIOLOGICAL:** Ipilimumab

## Key facts

- **NCT ID:** NCT01950195
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2016-09
- **Final completion:** —
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Local IRB required us to submit amendment as a separate study.
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01950195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01950195, "SRS (Stereotactic Radiosurgery) Plus Ipilimumab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01950195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*